SYoung Group Co., Ltd.

XSEC:300740 Stock Report

Market Cap: CN¥5.0b

SYoung Group Valuation

Is 300740 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300740 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300740 (CN¥12.82) is trading below our estimate of fair value (CN¥45.98)

Significantly Below Fair Value: 300740 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300740?

Key metric: As 300740 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 300740. This is calculated by dividing 300740's market cap by their current earnings.
What is 300740's PE Ratio?
PE Ratio23.9x
EarningsCN¥208.48m
Market CapCN¥4.98b

Price to Earnings Ratio vs Peers

How does 300740's PE Ratio compare to its peers?

The above table shows the PE ratio for 300740 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average29.2x
603896 Zhejiang Shouxiangu Pharmaceutical
18.4x19.4%CN¥4.3b
001328 Dencare (Chongqing) Oral Care
32.7x17.4%CN¥5.2b
301507 Hangzhou Minsheng Healthcare
51.7xn/aCN¥4.8b
605009 Hangzhou Haoyue Personal Care
14x16.4%CN¥6.0b
300740 SYoung Group
23.9x23.7%CN¥5.0b

Price-To-Earnings vs Peers: 300740 is good value based on its Price-To-Earnings Ratio (23.9x) compared to the peer average (29.9x).

Price to Earnings Ratio vs Industry

How does 300740's PE Ratio compare vs other companies in the CN Personal Products Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
300740 23.9xIndustry Avg. 34.7xNo. of Companies5PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 300740 is good value based on its Price-To-Earnings Ratio (23.9x) compared to the CN Personal Products industry average (34.7x).

Price to Earnings Ratio vs Fair Ratio

What is 300740's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300740 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.9x
Fair PE Ratio24.4x

Price-To-Earnings vs Fair Ratio: 300740 is good value based on its Price-To-Earnings Ratio (23.9x) compared to the estimated Fair Price-To-Earnings Ratio (24.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

SYoung Group

CN¥5.0b

Engages in the research and development, production, and sale of cosmetic products in China.

300740

CN¥12.82

7D

-7.7%

1Y

-19.4%

Byhealth

CN¥21.7b

Develops and sells dietary supplements.

300146

CN¥12.90

7D

-5.4%

1Y

-28.4%

Sirio Pharma

CN¥6.2b

Operates as a contract manufacturer for dietary supplement industry worldwide.

300791

CN¥26.60

7D

-5.6%

1Y

2.7%